ENALAPRIL IN HYPERTENSION AND CONGESTIVE HEART-FAILURE - OVERALL REVIEW OF EFFICACY AND SAFETY

被引：39

作者：

MONCLOA, F ^{[1
]}

SROMOVSKY, JA ^{[1
]}

WALKER, JF ^{[1
]}

DAVIES, RO ^{[1
]}

机构：

[1] MERCK SHARP & DOHME RES LABS,RAHWAY,NJ 07065

来源：

DRUGS | 1985年 / 30卷

关键词：

D O I：

10.2165/00003495-198500301-00012

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：82 / 89

页数：8

共 21 条

[1]

BRUNNER HR, 1984, HYPERTENSION ANGIOTE, P193

[2] EVALUATION OF A LONG-ACTING CONVERTING ENZYME-INHIBITOR (ENALAPRIL) FOR THE TREATMENT OF CHRONIC CONGESTIVE HEART-FAILURE [J].

CODY, RJ ;

COVIT, AB ;

SCHAER, GL ;

LARAGH, JH .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1983, 1 (04) :1154-1159

[3] ENALAPRIL WORLDWIDE EXPERIENCE [J].

DAVIES, RO ;

IRVIN, JD ;

KRAMSCH, DK ;

WALKER, JF ;

MONCLOA, F .

AMERICAN JOURNAL OF MEDICINE, 1984, 77 (2A) :23-35

[4] REVIEW OF THE OVERALL EXPERIENCE OF CAPTOPRIL IN HYPERTENSION [J].

FROHLICH, ED ;

COOPER, RA ;

LEWIS, EJ .

ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (07) :1441-1444

[5] EFFECTS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK-421 IN HUMAN HYPERTENSION [J].

GAVRAS, H ;

BIOLLAZ, J ;

WAEBER, B ;

BRUNNER, HR ;

GAVRAS, I ;

DAVIES, RO .

CLINICAL AND EXPERIMENTAL HYPERTENSION, 1982, 4 (1-2) :303-314

[6] DURATION OF ACTION AND SHORT-TERM HORMONAL RESPONSES TO ENALAPRIL (MK-421) IN NORMAL SUBJECTS [J].

GIVEN, BD ;

TAYLOR, T ;

HOLLENBERG, NK ;

WILLIAMS, GH .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (03) :436-441

[7]

Gomez H J, 1983, J Hypertens Suppl, V1, P65

[8]

Gomez H. J., 1984, DIURETICS, P263

[9]

GROSS DM, 1981, J PHARMACOL EXP THER, V216, P552

[10]

Hodsman G P, 1983, J Hypertens Suppl, V1, P109

← 1 2 3 →